Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 974

1.

Subtypes in eosinophilic granulomatosis with polyangiitis classified according to rheumatoid factor.

Inamo J, Kaneko Y, Ota Y, Takeuchi T.

Clin Rheumatol. 2019 Jul 17. doi: 10.1007/s10067-019-04680-5. [Epub ahead of print]

PMID:
31317422
2.

New PCNT candidate missense variant in a patient with oral and maxillofacial osteodysplasia: a case report.

Aoyama KI, Kimura M, Yamazaki H, Uchibori M, Kojima R, Osawa Y, Hosomichi K, Ota Y, Tanaka M, Yamada S, Nishimura G.

BMC Med Genet. 2019 Jul 16;20(1):126. doi: 10.1186/s12881-019-0858-z.

3.

[Clinicopathological Evaluation of Preoperative Chemotherapy Containing S-1 as a Treatment for Patients with Oral Squamous Cell Carcinoma during Waiting Time for Surgery].

Matsumiya Y, Imai T, Takeshita A, Meshii N, Katou I, Iwai S, Suematsu M, Omae M, Kanesaki T, Ota Y, Onishi T, Amino K, Sumi T, Niki A, Ueda M, Nakazawa M.

Gan To Kagaku Ryoho. 2019 Jun;46(6):1027-1031. Japanese.

PMID:
31273169
4.

Bronchogenic cyst removal via thoracoscopic surgery in the prone position: A case report and literature review.

Ota Y, Watanabe T, Takahashi K, Suda T, Tachibana S, Matsubayashi J, Nagakawa Y, Osaka Y, Katsumata K, Tsuchida A.

Int J Surg Case Rep. 2019 Jun 8;60:204-208. doi: 10.1016/j.ijscr.2019.05.064. [Epub ahead of print]

5.

Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24-positive pancreatic adenocarcinoma.

Shima H, Tsurita G, Wada S, Hirohashi Y, Yasui H, Hayashi H, Miyakoshi T, Watanabe K, Murai A, Asanuma H, Tokita S, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Nakae Y, Sugita O, Ito YM, Ota Y, Kimura Y, Kutomi G, Hirata K, Mizuguchi T, Imai K, Takemasa I, Sato N, Torigoe T.

Cancer Sci. 2019 Jun 20. doi: 10.1111/cas.14106. [Epub ahead of print]

6.

Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series.

Kubo T, Tsurita G, Hirohashi Y, Yasui H, Ota Y, Watanabe K, Murai A, Matsuo K, Asanuma H, Shima H, Wada S, Nakatsugawa M, Kanaseki T, Tsukahara T, Mizuguchi T, Hirata K, Takemasa I, Imai K, Sato N, Torigoe T.

Cancer Sci. 2019 Jun 17. doi: 10.1111/cas.14099. [Epub ahead of print]

7.

Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis.

Kitamura M, Tateishi Y, Sato S, Kitamura S, Ota Y, Muta K, Yamashita H, Uramatsu T, Obata Y, Mochizuki Y, Nishikido M, Izumo T, Harada T, Funakoshi S, Matsuo T, Tsujino A, Sakai H, Mukae H, Nishino T.

BMC Nephrol. 2019 Jun 7;20(1):210. doi: 10.1186/s12882-019-1400-4.

8.

Bacterial Cell Culture at the Single-cell Level Inside Giant Vesicles.

Morita M, Ota Y, Katoh K, Noda N.

J Vis Exp. 2019 Apr 30;(146). doi: 10.3791/59555.

PMID:
31107450
9.

Prediction of Nonadherence and Renal Prognosis by Pre-Transplantation Serum Phosphate Levels.

Kitamura M, Mochizuki Y, Kitamura S, Mukae Y, Nakanishi H, Ota Y, Muta K, Yamashita H, Obata Y, Iwata T, Nishikido M, Kawanami S, Takashima M, Sasaki H, Sakai H, Mukae H, Nishino T.

Ann Transplant. 2019 May 10;24:260-267. doi: 10.12659/AOT.914909.

10.

Multicenter, observational clinical study of abatacept in Japanese patients with rheumatoid arthritis.

Ogawa N, Ohashi H, Ota Y, Kobori K, Suzuki M, Tsuboi S, Hayakawa M, Goto Y, Karahashi T, Kimoto O, Miyamoto T, Furukawa S, Shimoyama K, Suzuki D, Maekawa Y.

Immunol Med. 2019 Mar;42(1):29-38. doi: 10.1080/25785826.2019.1605036. Epub 2019 May 8. Erratum in: Immunol Med. 2019 Jun 11;:1-3.

PMID:
31067155
11.

Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer.

Suzuki T, Shinozaki E, Osumi H, Nakayama I, Ota Y, Ichimura T, Ogura M, Wakatsuki T, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K.

Cancer Chemother Pharmacol. 2019 Aug;84(2):307-313. doi: 10.1007/s00280-019-03855-w. Epub 2019 May 7.

PMID:
31065729
12.

Definitive Radiotherapy for Older Patients Aged ≥75 Years With Localized Esophageal Cancer.

Suzuki G, Yamazaki H, Aibe N, Masui K, Kimoto T, Shimizu D, Nishimura T, Nakashima A, Machida K, Kawabata K, Ota Y, Fujiwara H, Ishikawa T, Yamada K.

In Vivo. 2019 May-Jun;33(3):925-932. doi: 10.21873/invivo.11560.

13.

A Simple and Easily Reproducible Model of Reversible Obstructive Jaundice in Rats.

Hiratani S, Mori R, Ota Y, Matsuyama R, Kumamoto T, Nagashima Y, Morioka D, Endo I.

In Vivo. 2019 May-Jun;33(3):699-706. doi: 10.21873/invivo.11528.

14.

Corrigendum: Nitrosomonas europaea MazF Specifically Recognises the UGG Motif and Promotes Selective RNA Degradation.

Miyamoto T, Yokota A, Ota Y, Tsuruga M, Aoi R, Tsuneda S, Noda N.

Front Microbiol. 2019 Apr 3;10:634. doi: 10.3389/fmicb.2019.00634. eCollection 2019.

15.

Fluorescent nucleic acid probe in droplets for bacterial sorting (FNAP-sort) as a high-throughput screening method for environmental bacteria with various growth rates.

Ota Y, Saito K, Takagi T, Matsukura S, Morita M, Tsuneda S, Noda N.

PLoS One. 2019 Apr 17;14(4):e0214533. doi: 10.1371/journal.pone.0214533. eCollection 2019.

16.

Blueberry Leaf Polyphenols Prevent Body Fat Accumulation in Mice Fed High-fat, High-sucrose Diet.

Fujii K, Ota Y, Nishiyama K, Kunitake H, Yamasaki Y, Tari H, Araki K, Arakawa T, Yamasaki M.

J Oleo Sci. 2019 May 1;68(5):471-479. doi: 10.5650/jos.ess18226. Epub 2019 Apr 9.

17.

Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.

Osumi H, Shinozaki E, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Takahari D, Ooki A, Suzuki T, Ota Y, Nakayama I, Chin K, Miki Y, Yamaguchi K.

Int J Cancer. 2019 Apr 9. doi: 10.1002/ijc.32320. [Epub ahead of print]

PMID:
30963570
18.

A Randomized Placebo-controlled Trial of an Oral Preparation of High Molecular Weight Fucoidan in Patients with Type 2 Diabetes with Evaluation of Taste Sensitivity.

Sakai C, Abe S, Kouzuki M, Shimohiro H, Ota Y, Sakinada H, Takeuchi T, Okura T, Kasagi T, Hanaki K.

Yonago Acta Med. 2019 Mar 28;62(1):14-23. eCollection 2019 Mar.

19.

Reduced long-term care cost by social participation among older Japanese adults: a prospective follow-up study in JAGES.

Saito M, Aida J, Kondo N, Saito J, Kato H, Ota Y, Amemiya A, Kondo K.

BMJ Open. 2019 Mar 30;9(3):e024439. doi: 10.1136/bmjopen-2018-024439.

20.

Safety and Efficacy of Low-Dose Prasugrel as Part of Triple Therapy With Aspirin and Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - From the TWMU-AF PCI Registry.

Otsuki H, Yamaguchi J, Kawamoto T, Yoshikawa M, Ebihara S, Tanaka K, Nakao M, Jujo K, Arashi H, Ota Y, Saito K, Takagi A, Tanaka H, Fujii S, Honda A, Mori F, Hagiwara N.

Circ J. 2019 Apr 25;83(5):1000-1005. doi: 10.1253/circj.CJ-18-1113. Epub 2019 Mar 27.

21.

Genetic Properties Responsible for the Transgressive Segregation of Days to Heading in Rice.

Koide Y, Sakaguchi S, Uchiyama T, Ota Y, Tezuka A, Nagano AJ, Ishiguro S, Takamure I, Kishima Y.

G3 (Bethesda). 2019 May 7;9(5):1655-1662. doi: 10.1534/g3.119.201011.

22.

Extremely Low Organ Toxicity and Strong Antitumor Activity of miR-34-Regulated Oncolytic Coxsackievirus B3.

Jia Y, Miyamoto S, Soda Y, Takishima Y, Sagara M, Liao J, Hirose L, Hijikata Y, Miura Y, Hara K, Iwanaga A, Ota Y, Tani K.

Mol Ther Oncolytics. 2019 Jan 25;12:246-258. doi: 10.1016/j.omto.2019.01.003. eCollection 2019 Mar 29.

23.

Important cytological findings for distinction between follicular variant and conventional papillary thyroid carcinoma, including noninvasive follicular thyroid tumors with papillary-like nuclear features.

Koshikawa T, Fujita N, Ueda N, Ota Y, Sasaki E, Murakami Y, Hosoda W, Yatabe Y, Hanai N, Higuchi M, Hirokawa M, Miyauchi A.

Endocr J. 2019 May 28;66(5):475-483. doi: 10.1507/endocrj.EJ18-0525. Epub 2019 Mar 14.

24.

A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study.

Suenaga M, Wakatsuki T, Mashima T, Ogura M, Ichimura T, Shinozaki E, Nakayama I, Osumi H, Ota Y, Takahari D, Chin K, Seimiya H, Yamaguchi K.

Invest New Drugs. 2019 Mar 6. doi: 10.1007/s10637-019-00749-9. [Epub ahead of print]

PMID:
30838483
25.

Surgical approaches for condylar fractures related to facial nerve injury: deep versus superficial dissection.

Imai T, Fujita Y, Motoki A, Takaoka H, Kanesaki T, Ota Y, Iwai S, Chisoku H, Ohmae M, Sumi T, Nakazawa M, Uzawa N.

Int J Oral Maxillofac Surg. 2019 Mar 1. pii: S0901-5027(19)30067-0. doi: 10.1016/j.ijom.2019.02.003. [Epub ahead of print]

PMID:
30833093
26.

Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.

Shiga T, Suzuki A, Haruta S, Mori F, Ota Y, Yagi M, Oka T, Tanaka H, Murasaki S, Yamauchi T, Katoh J, Hattori H, Kikuchi N, Watanabe E, Yamada Y, Haruki S, Kogure T, Suzuki T, Uetsuka Y, Hagiwara N; HIJ-HF II Investigators.

ESC Heart Fail. 2019 Jun;6(3):475-486. doi: 10.1002/ehf2.12418. Epub 2019 Mar 3.

27.

Analysis of predictive factors for R0 resection and immediate bleeding of cold snare polypectomy in colonoscopy.

Aoki T, Yoshida S, Abe H, Ono S, Nakada A, Ota Y, Narita A, Yoshikawa T, Kinoshita H, Tsuji Y, Yamada A, Fujishiro M, Hirata Y, Fukayama M, Koike K.

PLoS One. 2019 Mar 1;14(3):e0213281. doi: 10.1371/journal.pone.0213281. eCollection 2019.

28.

Accumulation of Liver Lipids Induced by Vitamin B6 Deficiency Was Effectively Ameliorated by Choline and, to a Lesser Extent, Betaine.

Kitagawa E, Ota Y, Hasegawa M, Nakagawa T, Hayakawa T.

J Nutr Sci Vitaminol (Tokyo). 2019;65(1):94-101. doi: 10.3177/jnsv.65.94.

29.

Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.

Kawaguchi H, Tsujino K, Miki M, Matsumoto Y, Ota Y, Hirokaga K, Takao S, Soejima T, Sasaki R.

Jpn J Clin Oncol. 2019 Jun 1;49(6):545-553. doi: 10.1093/jjco/hyz003.

PMID:
30796835
30.

Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.

Okano S, Enokida T, Onoe T, Ota Y, Motegi A, Zenda S, Akimoto T, Tahara M.

Int J Clin Oncol. 2019 Jul;24(7):789-797. doi: 10.1007/s10147-019-01418-w. Epub 2019 Feb 22.

PMID:
30796560
31.

p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia.

Yokoyama M, Shimizu I, Nagasawa A, Yoshida Y, Katsuumi G, Wakasugi T, Hayashi Y, Ikegami R, Suda M, Ota Y, Okada S, Fruttiger M, Kobayashi Y, Tsuchida M, Kubota Y, Minamino T.

J Mol Cell Cardiol. 2019 Apr;129:105-117. doi: 10.1016/j.yjmcc.2019.02.010. Epub 2019 Feb 18.

PMID:
30790589
32.

Significance of subepithelial deposits in patients diagnosed with IgA nephropathy.

Kitamura M, Obata Y, Ota Y, Muta K, Yamashita H, Harada T, Mukae H, Nishino T.

PLoS One. 2019 Feb 20;14(2):e0211812. doi: 10.1371/journal.pone.0211812. eCollection 2019.

33.

A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study).

Zenda S, Ota Y, Kiyota N, Okano S, Fujii M, Kitamura M, Takahashi S, Ueda T, Monden N, Yamanaka T, Tahara M.

Front Oncol. 2019 Jan 22;9:6. doi: 10.3389/fonc.2019.00006. eCollection 2019.

34.

Biallelic KARS pathogenic variants cause an early-onset progressive leukodystrophy.

Itoh M, Dai H, Horike SI, Gonzalez J, Kitami Y, Meguro-Horike M, Kuki I, Shimakawa S, Yoshinaga H, Ota Y, Okazaki T, Maegaki Y, Nabatame S, Okazaki S, Kawawaki H, Ueno N, Goto YI, Kato Y.

Brain. 2019 Mar 1;142(3):560-573. doi: 10.1093/brain/awz001.

PMID:
30715177
35.

Methotrexate-associated Lymphoproliferative Disorder: A Rare Differential Diagnosis of Wheezes.

Ujino M, Miyoshi S, Sugimoto N, Arai H, Ota Y, Sasajima Y, Kawamura M, Nagase H, Yamaguchi M, Ohta K.

Intern Med. 2019 Jun 15;58(12):1759-1764. doi: 10.2169/internalmedicine.2080-18. Epub 2019 Feb 1.

36.

Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.

Kitazawa T, Seo K, Yoshino Y, Asako K, Kikuchi H, Kono H, Ota Y.

J Infect Chemother. 2019 May;25(5):351-354. doi: 10.1016/j.jiac.2019.01.005. Epub 2019 Jan 31.

PMID:
30711257
37.

Multicenter retrospective study of the prognosis and treatment outcomes of Japanese oral squamous cell carcinoma patients with level IV/V metastasis.

Hasegawa T, Yanamoto S, Otsuru M, Kakei Y, Okura M, Yamakawa N, Yamada SI, Ota Y, Umeda M, Kirita T, Kurita H, Ueda M, Komori T; Japan Oral Oncology Group (JOOG).

Head Neck. 2019 Jul;41(7):2256-2263. doi: 10.1002/hed.25672. Epub 2019 Feb 1.

PMID:
30708395
38.

Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.

Nishikawa Y, Kodama Y, Shiokawa M, Matsumori T, Marui S, Kuriyama K, Kuwada T, Sogabe Y, Kakiuchi N, Tomono T, Mima A, Morita T, Ueda T, Tsuda M, Yamauchi Y, Sakuma Y, Ota Y, Maruno T, Uza N, Uesugi M, Kageyama R, Chiba T, Seno H.

Oncogene. 2019 May;38(22):4283-4296. doi: 10.1038/s41388-019-0718-5. Epub 2019 Jan 31.

PMID:
30705405
39.

Trousseau syndrome in a patient with advanced oral squamous cell carcinoma: a case report.

Aoyama KI, Tamura M, Uchibori M, Nakanishi Y, Arai T, Aoki T, Osawa Y, Kaneko A, Ota Y.

J Med Case Rep. 2019 Jan 29;13(1):26. doi: 10.1186/s13256-018-1833-6.

40.

Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.

Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronné L, Kogure Y, Sato Y, Nishida K, Gion Y, Shiraishi Y, Tanaka H, Chiba K, Watatani Y, Kakiuchi N, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Sanada M, Onozawa M, Teshima T, Yoshiki Y, Ishida T, Suzuki K, Shimada K, Tomita A, Kato M, Ota Y, Izutsu K, Demachi-Okamura A, Akatsuka Y, Miyano S, Yoshino T, Gaulard P, Hermine O, Takeuchi K, Ohshima K, Ogawa S.

Leukemia. 2019 Jul;33(7):1687-1699. doi: 10.1038/s41375-019-0380-5. Epub 2019 Jan 25.

PMID:
30683910
41.

The role of human rights in implementing socially responsible seafood.

Teh LCL, Caddell R, Allison EH, Finkbeiner EM, Kittinger JN, Nakamura K, Ota Y.

PLoS One. 2019 Jan 25;14(1):e0210241. doi: 10.1371/journal.pone.0210241. eCollection 2019.

42.

Predicting the survival of patients with bone metastases treated with radiation therapy: a validation study of the Katagiri scoring system.

Kubota H, Soejima T, Sulaiman NS, Sekii S, Matsumoto Y, Ota Y, Tsujino K, Fujita I, Fujimoto T, Morishita M, Ikegaki J, Matsumoto K, Sasaki R.

Radiat Oncol. 2019 Jan 18;14(1):13. doi: 10.1186/s13014-019-1218-z.

43.

A new species of the genus Elasmopus from Miyako Island, Japan (Crustacea: Amphipoda: Maeridae).

Nakamura Y, Nakano T, Ota Y, Tomikawa K.

Zootaxa. 2019 Jan 14;4544(3):395-406. doi: 10.11646/zootaxa.4544.3.5.

PMID:
30647247
44.

Application of a peripheral vein illumination device to reduce saphenous structure injury caused by screw insertion during arthroscopic ankle arthrodesis.

Nakasa T, Ikuta Y, Tsuyuguchi Y, Ota Y, Kanemitsu M, Adachi N.

J Orthop Sci. 2019 Jul;24(4):697-701. doi: 10.1016/j.jos.2018.12.007. Epub 2019 Jan 7.

PMID:
30630767
45.

A rapid and simple detection method for phenotypic antimicrobial resistance in Escherichia coli by loop-mediated isothermal amplification.

Ota Y, Furuhashi K, Nanba T, Yamanaka K, Ishikawa J, Nagura O, Hamada E, Maekawa M.

J Med Microbiol. 2019 Feb;68(2):169-177. doi: 10.1099/jmm.0.000903. Epub 2019 Jan 9.

PMID:
30624176
46.

Effectiveness of a comprehensive oral management protocol for the prevention of severe oral mucositis in patients receiving radiotherapy with or without chemotherapy for oral cancer: a multicentre, phase II, randomized controlled trial.

Kawashita Y, Koyama Y, Kurita H, Otsuru M, Ota Y, Okura M, Horie A, Sekiya H, Umeda M.

Int J Oral Maxillofac Surg. 2019 Jul;48(7):857-864. doi: 10.1016/j.ijom.2018.10.010. Epub 2019 Jan 2.

PMID:
30611598
47.

Nested Polymerase Chain Reaction with Specific Primers for Mucorales in the Serum of Patients with Hematological Malignancies.

Hirano M, Ota Y, Koibuchi T, Takei T, Takeda R, Kawamata T, Yokoyama K, Uchimaru K, Yotsuyanagi H, Imai Y, Tojo A.

Jpn J Infect Dis. 2019 May 23;72(3):196-198. doi: 10.7883/yoken.JJID.2018.379. Epub 2018 Dec 25.

48.

A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m2 cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors.

Isohashi F, Takano T, Onuki M, Arimoto T, Kawamura N, Hara R, Kawano Y, Ota Y, Inokuchi H, Shinjo H, Saito T, Fujiwara S, Sawasaki T, Ando K, Horie K, Okamoto H, Murakami N, Hasumi Y, Kasamatsu T, Toita T.

Int J Clin Oncol. 2019 May;24(5):575-582. doi: 10.1007/s10147-018-01380-z. Epub 2018 Dec 22.

49.

Two cases of Tullio phenomenon in which oval and round window reinforcement surgery was effective.

Suzuki M, Okamoto T, Ushio M, Ota Y.

Auris Nasus Larynx. 2019 Aug;46(4):636-640. doi: 10.1016/j.anl.2018.10.022. Epub 2018 Dec 17.

PMID:
30573214
50.

Unraveling the blue paradox: Incomplete analysis yields incorrect conclusions about Phoenix Islands Protected Area closure.

Hanich Q, Rotjan R, Aqorau T, Bailey M, Campbell B, Gray N, Gruby R, Hampton J, Ota Y, Parris H, Reid C, Sumaila UR, Swartz W.

Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12122-E12123. doi: 10.1073/pnas.1815600115. Epub 2018 Dec 17. No abstract available.

Supplemental Content

Support Center